Arbutus Biopharma所有资讯

Arbutus Biopharma | 4：持股变动声明-董事 BURGESS DANIEL D

05/24 15:24

Arbutus Biopharma | 4：持股变动声明-董事 Rewolinski Melissa

05/24 15:22

Arbutus Biopharma | 4：持股变动声明-董事 MANCHESTER KEITH S

05/24 15:20

Arbutus Biopharma | 4：持股变动声明-董事 Meyers James R

05/24 15:19

Arbutus Biopharma | 4：持股变动声明-董事 HENRIQUES RICHARD C JR

05/24 15:18

Arbutus Biopharma | 4：持股变动声明-董事 Torti Frank

05/24 15:13

Arbutus Biopharma | SC 13D/A：超过5%持股股东披露文件(修正)-Whitefort Capital Master Fund, LP(6.8%),Whitefort Capital GP, LLC(6.8%)等

05/17 08:07

Arbutus Biopharma | SC 13D：超过5%持股股东披露文件-Whitefort Capital Master Fund, LP(6.8%),Whitefort Capital GP, LLC(6.8%)等

05/09 07:02

Arbutus Biopharma | SC 13G/A：超过5%持股股东披露文件(修正)-Whitefort Capital Management, LP(7.9%),David Salanic(7.9%)等

02/14 15:46

Arbutus Biopharma | SC 13G/A：超过5%持股股东披露文件(修正)-Two Seas Capital LP(5.4%),Two Seas Capital GP LLC(5.4%)等

02/14 09:52

Arbutus Biopharma | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(6.2%)

02/12 08:44

Arbutus Biopharma | 4：持股变动声明-高管 Naftzger J. Christopher

02/05 18:59

Arbutus Biopharma | 4：持股变动声明-高管 Sims Karen

02/05 18:59

Arbutus Biopharma | 4：持股变动声明-高管 HASTINGS DAVID C

02/05 18:59

Arbutus Biopharma | 4：持股变动声明-高管 Sofia Michael J.

02/05 18:58

Arbutus Biopharma | 4：持股变动声明-高管 McElhaugh Michael J.

02/05 18:58

Arbutus Biopharma | SC 13G：超过5%持股股东披露文件-Two Seas Capital LP(5.7%),Two Seas Capital GP LLC(5.7%)等

2023/11/21 07:00

Arbutus Biopharma | SC 13G：超过5%持股股东披露文件-Whitefort Capital Management, LP(6.0%),David Salanic(6.0%)等

2023/09/11 16:07

Arbutus Biopharma | 4：持股变动声明-董事 Rewolinski Melissa

2023/07/13 15:13

Arbutus Biopharma | 3：首次持股声明-董事 Rewolinski Melissa

2023/07/13 15:11